Page last updated: 2024-11-04

pantolactone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

pantolactone: degradation product of pantothenic acid in liver; RN given refers to (+-)-isomer; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

(R)-pantolactone : A butan-4-olide that is dihydrofuran-2(3H)-one substituted by a hydroxy group at position 3 and two methyl groups at position 4 (the R-stereoisomer). [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID439368
CHEMBL ID4587869
CHEBI ID16719
SCHEMBL ID1164270
MeSH IDM0046939

Synonyms (77)

Synonym
(3r)-3-hydroxy-4,4-dimethyldihydrofuran-2(3h)-one
CHEBI:16719
2(3h)-furanone, dihydro-3-hydroxy-4,4-dimethyl-, (r)-
pantolactone
(3r)-dihydro-3-hydroxy-4,4-dimethyl-2(3h)-furanone
599-04-2
d-pantolactone
(r)-pantolactone
C01012
(r)-pantoyl lactone
d-(-)-pantolactone, 99%
pantoyl lactone
pantoic acid gamma-lactone
BMSE000381
(3r)-3-hydroxy-4,4-dimethyloxolan-2-one
d-(-)-pantoyl lactone
d-(-)-2-hydroxy-3,3-dimethyl-gamma-butyrolactone
(r)-(-)-dihydro-3-hydroxy-4,4-dimethyl-2(3h)-furanone
d-(-)-pantolactone
P0011
(3r)-3-hydroxy-4,4-dimethyl-tetrahydrofuran-2-one
AKOS006238310
j288d7o0js ,
(-)-2-hydroxy-3,3-dimethyl-.gamma.-butyrolacton
ec 209-963-3
einecs 209-963-3
unii-j288d7o0js
alpha-hydroxy-beta,beta-dimethyl-gamma-butyrolactone
2(3h)-furanone, dihydro-3-hydroxy-4,4-dimethyl-, (3r)-
2(3h)-furanone, dihydro-3-hydroxy-4,4-dimethyl-, (theta)-
pantothenic lactone
(3r)-tetrahydro-3-hydroxy-4,4-dimethylfuran-2-one
pantolactone [inci]
pantolactone, r-isomer
pantolactone [usp-rs]
pantolactone, (-)-
d-(-)-.alpha.-hydroxy-.beta.,.beta.-dimethyl-.gamma.-butyrolactone
(r)-.alpha.-hydroxy-.beta.,.beta.-dimethyl-.gamma.-butyrolactone
dexpanthenol impurity c [ep impurity]
pantolactone [mi]
(r)-(-)-pantolactone
pantolactone, r-(-)-
pantolactone, (r)-
S6027
SCHEMBL1164270
(r)-3-hydroxy-4,4-dimethyldihydrofuran-2(3h)-one
(r)-3-hydroxy-4,4-dimethyl-dihydrofuran-2(3h)-one
(r)-(-)pantolactone
d-(-)-pantolyl lactone
3-hydroxy-4,4-dimethyldihydro-2(3h)-furanone-, d-(-)- #
2(3h)-furanone, dihydro-3-hydroxy-4,4-dimethyl-, d-(-)-
(d)-pantolactone
pantolyl lactone
d-(-)-pantoic acid lactone
d-(-)-.alpha.hydroxy-.beta.,.beta.-dimethyl-.gamma.-butyrolactone
d(-)-2-hydroxy-3,3-dimethyl-.gamma.-butyrolactone
d-(-)-4-hydroxyphenylglycine dane salt (methyl potassium)
Q-200920
(3r)-4,4-dimethyl-3-oxidanyl-oxolan-2-one
mfcd00005392
d-(-)-pantolactone, puriss., >=99.0% (t)
pantolactone, united states pharmacopeia (usp) reference standard
pantolactone, pharmaceutical secondary standard; certified reference material
DTXSID90881249
HY-W010396
Q27102042
AS-14054
AC1149
CS-W011112
d-(?)-pantolactone
CHEMBL4587869
dihydro-3-hydroxy-4,4-dimethyl- 2(3h)-furanone
(r)-3-hydroxy-4,4-dimethyl-dihydro-furan-2-one
(3r)-3-hydroxy-4,4-dimethyldihydrofuran-2(3h)-one (pantolactone)
EN300-67110
(r)-(-)-pantolactone pantoic acid gamma-lactone (r)-(-)-beta,beta-dimethyl-alpha-hydroxy-gamma-butyrolactone (r)-(-)-alpha-hydroxy-beta,beta-dimethyl-gamma-butyrolactone (r)-(-)-4,5-dihydro-3-hydroxy-4,4-dimethyl-2(3h)-furanone d-(-)-alpha-hydroxy-beta,be
Z1065885480
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
Saccharomyces cerevisiae metaboliteAny fungal metabolite produced during a metabolic reaction in Baker's yeast (Saccharomyces cerevisiae).
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
butan-4-olideAny gamma-lactone having the lactone moiety derived from 4-hydroxybutanoic acid.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (3)

PathwayProteinsCompounds
phosphopantothenate biosynthesis II011
phosphopantothenate biosynthesis II012
Pantothenate and coenzyme A biosynthesis III119
Pantothenate biosynthesis III17

Bioassays (1)

Assay IDTitleYearJournalArticle
AID1601336Inhibition of mouse FAS at 80 uM preincubated for 30 mins in presence of acetyl coenzyme A and NADPH followed by malonyl coenzyme A addition and measured after 3 mins by spectrophotometric analysis2019Bioorganic & medicinal chemistry, 10-15, Volume: 27, Issue:20
Synthesis, biological activities, and docking studies of d-pantolactone derivatives as novel FAS inhibitors.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (47)

TimeframeStudies, This Drug (%)All Drugs %
pre-199013 (27.66)18.7374
1990's6 (12.77)18.2507
2000's11 (23.40)29.6817
2010's13 (27.66)24.3611
2020's4 (8.51)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (2.04%)6.00%
Case Studies1 (2.04%)4.05%
Observational0 (0.00%)0.25%
Other47 (95.92%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]